跳至主要内容
临床试验/JPRN-UMIN000003719
JPRN-UMIN000003719已完成2 期

A Phase II Study of Paclitaxel+S-1 for previously treated Non-Small Cell Lung Cancer - A Phase II Study of Paclitaxel+S-1 for previously treated Non-Small Cell Lung Cancer

Osaka Medical Center for Cancer and Cardiovascular Diseases0 个研究点目标入组 50 人开始时间: 2010年6月6日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 75years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1)uncontrollablenangina pectoris, arrythmia or heart failure 2)Hystory of active double cancer 3)complication of superior vena cava syndrome 4)complication ofliver cirrhosis 5)Interstitial pneumonaitis on chest x-ray 6)complication ofgastrointestinal bleeding 7)poorly controled diabetes mellitus 8)symptoms of ileus or watery diarrhea 9)Patients with serious infections or susupected infections with fever 10)complication of massive pericardial effusion, ascites or pleural sffusion 11)Pregnant or lactating woman 12)Symptomatic brain metastasis 13)Patients whose participation in the trial is judged to be inappropriate by the attending doctor.

研究者

发起方
Osaka Medical Center for Cancer and Cardiovascular Diseases

相似试验